Acellera is a pioneering technology company specializing in developing and applying advanced computational methods to accelerate research in drug discovery, biomolecular research, and materials science. They are renowned for their high-performance molecular dynamics (MD) software, such as ACEMD, which leverages GPU technology to achieve unprecedented simulation speeds. Acellera also offers user-friendly platforms like PlayMolecule for broader access to complex simulation tools and HTMD (High-Throughput Molecular Dynamics) for managing and analyzing large MD datasets. Their solutions empower researchers in pharmaceutical companies, biotech firms, and academic institutions worldwide to gain deeper insights into molecular mechanisms and design better drugs and materials.
The Barcelona headquarters serves as the central hub for Acellera's research and development, software engineering, business operations, and strategic partnerships. It's where core product development and scientific innovation take place.
Situated within the Barcelona Science Park (Parc Científic Barcelona), providing access to a collaborative ecosystem of research groups, biotech companies, and advanced scientific facilities.
Acellera fosters a dynamic, innovative, and scientifically-driven work culture. Employees, often with strong backgrounds in physics, chemistry, computer science, and biology, collaborate in a research-intensive environment focused on solving complex scientific challenges using cutting-edge computational tools.
The Barcelona location is strategically important due to its proximity to leading universities, research centers, and a thriving biotech industry, facilitating talent acquisition and scientific collaborations across Europe.
Acellera supports a global clientele of pharmaceutical companies, biotech firms, and academic research institutions across North America, Europe, and Asia. Their functions supported globally include software licensing and distribution of their flagship products (ACEMD, PlayMolecule, HTMD), dedicated technical support, scientific consulting services for complex molecular modeling and drug discovery projects, and fostering international research collaborations. While physical offices are concentrated in Spain, the UK, and the US, their reach and support extend worldwide through digital platforms and partnerships.
Barcelona Science Park, Carrer de Baldiri Reixac, 10, Office 2.20
Barcelona
Catalonia
Spain
Address: London BioScience Innovation Centre, 2 Royal College St, London NW1 0NH, United Kingdom
To serve clients and partners in the United Kingdom and potentially Northern Europe, leveraging London's status as a global hub for biotech and finance.
Address: Cambridge, MA, USA (Specific street address not publicly listed for general office; likely a representative or shared office space for US operations)
To facilitate engagement with US-based pharmaceutical companies, research institutions, and academic collaborators, providing local support for Acellera's software and services.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Acellera Therapeutics' leadership includes:
Acellera Therapeutics has been backed by several prominent investors over the years, including:
No major high-profile executive hires or departures at the C-suite level have been publicly announced by Acellera in the last 12 months. The company maintains a stable leadership team focused on its core scientific and technological advancements.
Discover the tools Acellera Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Acellera commonly uses the email format combining the first initial of an employee's name followed by their last name. This is a standard professional format.
[first_initial][last]@acellera.com
Format
jdoe@acellera.com
Example
90%
Success rate
Acellera News • May 15, 2024
Acellera and Intel to Present at ISC High Performance 2024: Innovations in GPU-Accelerated Molecular Dynamics. The presentation will focus on recent advancements in ACEMD3, leveraging Intel’s GPU technology for enhanced simulation performance....more
Acellera News • March 7, 2024
Acellera Achieves ISO 27001 Certification for Information Security Management, demonstrating its commitment to the highest standards of data security for its clients and partners in the drug discovery and biotech sectors....more
EIC Community (European Innovation Council) • October 19, 2023
EIC Interview with Gianni De Fabritiis, Founder of Acellera, discussing the company's journey, innovations in GPU-accelerated drug discovery, and the impact of EIC funding on their growth and research capabilities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Acellera Therapeutics, are just a search away.